Terms: = Germ cell tumor AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Prognosis
12 results:
1. The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics.
Deng Z; Richardson DR
Pharmacol Rev; 2023 Sep; 75(5):1007-1035. PubMed ID: 37280098
[TBL] [Abstract] [Full Text] [Related]
2. Overexpression of INSM1, NOTCH1, NEUROD1, and YAP1 genes is associated with adverse clinical outcome in pediatric neuroblastoma.
Metovic J; Napoli F; Osella-Abate S; Bertero L; Tampieri C; Orlando G; Bianchi M; Carli D; Fagioli F; Volante M; Papotti M
Virchows Arch; 2022 Dec; 481(6):925-933. PubMed ID: 36121500
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors.
Metovic J; La Salvia A; Rapa I; Napoli F; Birocco N; Pia Bizzi M; Garcia-Carbonero R; Ciuffreda L; Scagliotti G; Papotti M; Volante M
Endocr Pathol; 2022 Sep; 33(3):388-399. PubMed ID: 35608806
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Pathogenesis of Merkel cell Carcinoma.
DeCaprio JA
Annu Rev Pathol; 2021 Jan; 16():69-91. PubMed ID: 33228463
[TBL] [Abstract] [Full Text] [Related]
5. A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.
Jung M; Russell AJ; Liu B; George J; Liu PY; Liu T; DeFazio A; Bowtell DD; Oberthuer A; London WB; Fletcher JI; Haber M; Norris MD; Henderson MJ
Cancer Res; 2017 Feb; 77(4):971-981. PubMed ID: 27923830
[TBL] [Abstract] [Full Text] [Related]
6. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract] [Full Text] [Related]
7. Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells.
Chayka O; D'Acunto CW; Middleton O; Arab M; Sala A
J Biol Chem; 2015 Jan; 290(4):2198-212. PubMed ID: 25477524
[TBL] [Abstract] [Full Text] [Related]
8. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.
Ryan SL; Schwalbe EC; Cole M; Lu Y; Lusher ME; Megahed H; O'Toole K; Nicholson SL; Bognar L; Garami M; Hauser P; Korshunov A; Pfister SM; Williamson D; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2012 Apr; 123(4):501-13. PubMed ID: 22139329
[TBL] [Abstract] [Full Text] [Related]
9. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
[TBL] [Abstract] [Full Text] [Related]
10. Alteration in length of telomeric repeats in lung cancer.
Shirotani Y; Hiyama K; Ishioka S; Inyaku K; Awaya Y; Yonehara S; Yoshida Y; Inai K; Hiyama E; Hasegawa K
Lung Cancer; 1994 Jul; 11(1-2):29-41. PubMed ID: 8081703
[TBL] [Abstract] [Full Text] [Related]
11. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
[TBL] [Abstract] [Full Text] [Related]
12. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract] [Full Text] [Related]
